Immune Secretomes Targeting Age-Acquired Immune Decline

Time: 12:00 pm
day: Day Two


  • Discussing the association of aging and a decline in secretory factors that benefit immune system development, modulation and health
  • Describing the novel method of growing human stem cells for clinical use and directing them to produce a secretome (STEM)
  • Revealing an FDA-approved Phase 1/2a human clinical trial to test the safety and efficacy of STEM in elderly patients with muscle atrophy related to knee osteoarthritis